InnoSer offers new in vivo imaging capabilities

InnoSer offers new in vivo imaging capabilities

InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...
InnoSer welcomes Edith Simar as its new Business Development Manager

InnoSer welcomes Edith Simar as its new Business Development Manager

Starting from September 2020, Edith Simar joined the InnoSer team as a business development manager. Thanks to her earlier work and connections in Belgium, France, and Luxembourg Edith will especially strengthen InnoSer’s relationships with (prospective) French...
Midbrain Organoids Free Webinar With Javier Jarazo

Midbrain Organoids Free Webinar With Javier Jarazo

InnoSer is inviting all interested in using midbrain organoids as a platform for Parkinson’s disease drug development to its webinar organized in collaboration with OrganoTherapeutics. The presentation outlining the platform characteristics and use will be given...
A day in the life of InnoSer senior research associate Laura Blockken

A day in the life of InnoSer senior research associate Laura Blockken

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
Towards Personalized Medicine By The Early Use Of Patient Data

Towards Personalized Medicine By The Early Use Of Patient Data

OPINION Traditional approaches to clinical drug development have created a critical gap between preclinical research and patient applications. Only the drugs that pass big clinical trials reach to the clinic, and a potentially heterogeneous group of patients end up...